Pulse Wave Diagnosis Helps Estimate Cardiovascular Risk
|
By HospiMedica International staff writers Posted on 08 Apr 2014 |

Image: Dr. Empar Lurbe Ferrer conducting a fundus examination (Photo courtesy of Hospital General de Valencia).
New software helps clinicians assess future cardiovascular risk by examining the structure of the eye in children.
Researchers at Hospital General de Valencia (Spain), Universitat Politècnica de València (Spain), and the Ophthalmology Unit of the Foundation for the Health and Biomedical Research of the Comunitat Valenciana (FISABIO-Oftalmología Médica, Valencia, Spain) have developed specialized software to make an in-depth study of the retinal microvascular architecture in children born with low birth-weight.
Pediatric patients undergo various noninvasive tests and all of them are interpreted together, giving as a result an approximation of what is happening in the children’s vessels. Among the tests are pulse wave morphology and speed of the blood as it travels through the vessels, and how it returns. Another test is a fundus scan with a nonmydriatic retinal camera to define the caliber and the branching angle of the retinal vessels to understand blood circulation. The measurements can indicate if a child who has a different branching angle could have an increase in blood pressure over the years.
Using the software, the researchers and pediatricians are analyzing the relationship between the various measurements and adult diseases such as hypertension or cardiovascular problems. By learning more about the retinal attributes of these pathologies as they appear in the newborn, the researchers can possibly determine characteristics that could imply a higher cardiovascular risk when the child reaches adulthood.
“Children with intrauterine growth retardation are those who are at a greater risk of developing cardiovascular diseases, such as hypertension or type 2 diabetes,” said Empar Lurbe Ferrer, MD, head of the pediatrics unit at Hospital General de Valencia. “Because of this, we are using the measurements to see if the branching angles of the vessels of children who have intrauterine growth retardation are different than those who do not.”
“This joint work between engineers and pediatricians aims to provide better care for pediatric patients,” said telecommunication engineer Sandra Morales, a researcher at the LabHuman technology center of the Universitat Politècnica de València. “Our system permits us to establish objective connections between different vessels and help clinical staff to detect these pathologies at the earliest stage. As a result they will help give more personalized treatments.”
Related Links:
Hospital General de Valencia
Universitat Politècnica de València
Foundation for the Health and Biomedical Research of the Comunitat Valenciana
Researchers at Hospital General de Valencia (Spain), Universitat Politècnica de València (Spain), and the Ophthalmology Unit of the Foundation for the Health and Biomedical Research of the Comunitat Valenciana (FISABIO-Oftalmología Médica, Valencia, Spain) have developed specialized software to make an in-depth study of the retinal microvascular architecture in children born with low birth-weight.
Pediatric patients undergo various noninvasive tests and all of them are interpreted together, giving as a result an approximation of what is happening in the children’s vessels. Among the tests are pulse wave morphology and speed of the blood as it travels through the vessels, and how it returns. Another test is a fundus scan with a nonmydriatic retinal camera to define the caliber and the branching angle of the retinal vessels to understand blood circulation. The measurements can indicate if a child who has a different branching angle could have an increase in blood pressure over the years.
Using the software, the researchers and pediatricians are analyzing the relationship between the various measurements and adult diseases such as hypertension or cardiovascular problems. By learning more about the retinal attributes of these pathologies as they appear in the newborn, the researchers can possibly determine characteristics that could imply a higher cardiovascular risk when the child reaches adulthood.
“Children with intrauterine growth retardation are those who are at a greater risk of developing cardiovascular diseases, such as hypertension or type 2 diabetes,” said Empar Lurbe Ferrer, MD, head of the pediatrics unit at Hospital General de Valencia. “Because of this, we are using the measurements to see if the branching angles of the vessels of children who have intrauterine growth retardation are different than those who do not.”
“This joint work between engineers and pediatricians aims to provide better care for pediatric patients,” said telecommunication engineer Sandra Morales, a researcher at the LabHuman technology center of the Universitat Politècnica de València. “Our system permits us to establish objective connections between different vessels and help clinical staff to detect these pathologies at the earliest stage. As a result they will help give more personalized treatments.”
Related Links:
Hospital General de Valencia
Universitat Politècnica de València
Foundation for the Health and Biomedical Research of the Comunitat Valenciana
Latest Critical Care News
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
- Cancer-Seeking Microbubbles Make Tumor Cells Self-Destruct
- Eye Movement Tests Uncover Hidden Brain Changes Years After Concussion
- Simple 5-Minute Questionnaire Test Speeds Endometriosis Diagnosis
Channels
Artificial Intelligence
view channel
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
AI Tool Maps Early Risk Patterns in Bloodstream Infections
Bloodstream infections can deteriorate rapidly and carry high mortality, especially in immunocompromised patients. Clinicians need reliable early risk stratification to prioritize monitoring and organ support.... Read moreSurgical Techniques
view channel
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Handheld Robotic System Expands Options for Total Knee Surgery
Orthopedic teams vary in their adoption of robotics, with some surgeons favoring intraoperative decision-making and a manual instrument feel, while others rely on preoperative, computed tomography–based... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channelMedtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
Medtronic announced a multiyear renewal and significant expansion of its global strategic alliance with GE HealthCare across Patient Care Solutions. Building on more than three decades of collaboration,... Read more
Quantum Surgical Acquires NeuWave from Johnson & Johnson
Quantum Surgical announced that it has acquired NeuWave Medical from Johnson & Johnson. NeuWave’s microwave ablation system is used in percutaneous tumor ablation procedures, and the acquisition supports... Read more
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more







